glp-1 agonists and sglt2 inhibitors Blood Pressure-Lowering Effects of Receptor https://link.springer.com/article/10.1007/s11906-025-01342-7 APhA 2025: GLP-1 Receptor Agonists

found that non-diabetic women with PCO and a BMI of 30 kg/m2 or less and 45 kg/m2 or less lost weight following 24 weeks of weekly EX-LAR or Dapagliflozin

adults without diabetes using these drugs

Binge Shopping, Gambling, and Compulsive Behaviors Reports are emerging regarding GLP-1 effectiveness at mitigating behavioral addictions such as gambling, compulsive shopping, and skin-picking

Sanyal Arun J, Pierre B, Mandy F, Neff Guy W, Eric L, Elisabetta B et al

Dysregulation of inflammasomes is closely linked to numerous human diseases, including neurodegenerative diseases, cancers, and vascular diseases

Diabetologia 65(Suppl 1):S289S289 Patel H, Khunti K, Rodbard HW et al (2022) Tirzepatide-induced weight loss in type 2 diabetes is independent of nausea, vomiting, or diarrhoea